Laidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking Therapeutics.
dan2023-03-31T03:30:28-04:00Laidlaw is pleased to act as Co-Manager on Vikings 287.5mm dollar offering. Laidlaw Capital Markets was the Sole Book Runner on Viking’s 27.6mm dollar IPO in 2015. VKTX is now over a one billion dollar company brought to market off the Laidlaw launchpad. Read Article
Stay In Touch